DELCATH SYSTEMS INC (DCTH) Fundamental Analysis & Valuation
NASDAQ:DCTH • US24661P8077
Current stock price
10.05 USD
+0.17 (+1.72%)
Last:
This DCTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DCTH Profitability Analysis
1.1 Basic Checks
- DCTH had positive earnings in the past year.
- DCTH had a positive operating cash flow in the past year.
- DCTH had negative earnings in 4 of the past 5 years.
- In the past 5 years DCTH reported 4 times negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.18%, DCTH is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
- DCTH's Return On Equity of 2.43% is fine compared to the rest of the industry. DCTH outperforms 73.94% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 0.45%, DCTH is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.18% | ||
| ROE | 2.43% | ||
| ROIC | 0.45% |
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DCTH has a better Profit Margin (3.17%) than 73.94% of its industry peers.
- With a decent Operating Margin value of 0.77%, DCTH is doing good in the industry, outperforming 65.96% of the companies in the same industry.
- DCTH has a Gross Margin of 86.16%. This is amongst the best in the industry. DCTH outperforms 95.21% of its industry peers.
- In the last couple of years the Gross Margin of DCTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.77% | ||
| PM (TTM) | 3.17% | ||
| GM | 86.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
2. DCTH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DCTH is destroying value.
- Compared to 1 year ago, DCTH has more shares outstanding
- The number of shares outstanding for DCTH has been increased compared to 5 years ago.
- DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 12.37 indicates that DCTH is not in any danger for bankruptcy at the moment.
- The Altman-Z score of DCTH (12.37) is better than 92.02% of its industry peers.
- DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.37 |
ROIC/WACC0.05
WACC8.93%
2.3 Liquidity
- DCTH has a Current Ratio of 10.92. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
- DCTH has a Current ratio of 10.92. This is amongst the best in the industry. DCTH outperforms 94.68% of its industry peers.
- DCTH has a Quick Ratio of 9.98. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of DCTH (9.98) is better than 95.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.92 | ||
| Quick Ratio | 9.98 |
3. DCTH Growth Analysis
3.1 Past
- DCTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
- The Revenue has grown by 129.08% in the past year. This is a very strong growth!
- The Revenue has been growing by 120.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%
3.2 Future
- The Earnings Per Share is expected to grow by 80.28% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 22.01% on average over the next years. This is a very strong growth
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue Next Year22.68%
Revenue Next 2Y27.81%
Revenue Next 3Y25.62%
Revenue Next 5Y22.01%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. DCTH Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 143.57, the valuation of DCTH can be described as expensive.
- DCTH's Price/Earnings ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 64.89% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.91, DCTH is valued quite expensively.
- The Price/Forward Earnings ratio is 259.29, which means the current valuation is very expensive for DCTH.
- Based on the Price/Forward Earnings ratio, DCTH is valued a bit cheaper than 65.43% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of DCTH to the average of the S&P500 Index (23.68), we can say DCTH is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.57 | ||
| Fwd PE | 259.29 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DCTH is valued a bit cheaper than 63.30% of the companies in the same industry.
- 93.09% of the companies in the same industry are more expensive than DCTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.65 | ||
| EV/EBITDA | 227.96 |
4.3 Compensation for Growth
- DCTH's earnings are expected to grow with 123.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y147.39%
EPS Next 3Y123.09%
5. DCTH Dividend Analysis
5.1 Amount
- No dividends for DCTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DCTH Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:DCTH (4/10/2026, 2:20:42 PM)
10.05
+0.17 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26 2026-02-26/bmo
Earnings (Next)05-06 2026-05-06
Inst Owners50.2%
Inst Owner Change0%
Ins Owners2.92%
Ins Owner Change1%
Market Cap349.24M
Revenue(TTM)85.23M
Net Income(TTM)2.70M
Analysts84.62
Price Target22.59 (124.78%)
Short Float %12.21%
Short Ratio8.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.28%
Min EPS beat(2)-1.96%
Max EPS beat(2)20.51%
EPS beat(4)3
Avg EPS beat(4)72.29%
Min EPS beat(4)-1.96%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-11.78%
EPS beat(12)6
Avg EPS beat(12)-19.4%
EPS beat(16)7
Avg EPS beat(16)-18.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)-0.02%
Revenue beat(4)2
Avg Revenue beat(4)3.85%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14.28%
Revenue beat(12)6
Avg Revenue beat(12)1.9%
Revenue beat(16)9
Avg Revenue beat(16)7.21%
PT rev (1m)-4.32%
PT rev (3m)-4.32%
EPS NQ rev (1m)-233.35%
EPS NQ rev (3m)-292.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-89.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.57%
Revenue NY rev (1m)-3.61%
Revenue NY rev (3m)-11.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.57 | ||
| Fwd PE | 259.29 | ||
| P/S | 4.1 | ||
| P/FCF | 16.65 | ||
| P/OCF | 15.51 | ||
| P/B | 3.14 | ||
| P/tB | 3.14 | ||
| EV/EBITDA | 227.96 |
EPS(TTM)0.07
EY0.7%
EPS(NY)0.04
Fwd EY0.39%
FCF(TTM)0.6
FCFY6%
OCF(TTM)0.65
OCFY6.45%
SpS2.45
BVpS3.2
TBVpS3.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.18% | ||
| ROE | 2.43% | ||
| ROCE | 0.59% | ||
| ROIC | 0.45% | ||
| ROICexc | 2.35% | ||
| ROICexgc | 2.35% | ||
| OM | 0.77% | ||
| PM (TTM) | 3.17% | ||
| GM | 86.16% | ||
| FCFM | 24.6% |
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 650% | ||
| Cap/Sales | 1.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 2507.35% | ||
| Profit Quality | 776.63% | ||
| Current Ratio | 10.92 | ||
| Quick Ratio | 9.98 | ||
| Altman-Z | 12.37 |
F-Score7
WACC8.93%
ROIC/WACC0.05
Cap/Depr(3y)370.83%
Cap/Depr(5y)273.47%
Cap/Sales(3y)2.04%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%
Revenue Next Year22.68%
Revenue Next 2Y27.81%
Revenue Next 3Y25.62%
Revenue Next 5Y22.01%
EBIT growth 1Y105.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year913.35%
EBIT Next 3Y331.54%
EBIT Next 5YN/A
FCF growth 1Y208.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.53%
OCF growth 3YN/A
OCF growth 5YN/A
DELCATH SYSTEMS INC / DCTH Fundamental Analysis FAQ
What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to DCTH.
What is the valuation status of DELCATH SYSTEMS INC (DCTH) stock?
ChartMill assigns a valuation rating of 4 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.
How profitable is DELCATH SYSTEMS INC (DCTH) stock?
DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for DCTH stock?
The Price/Earnings (PE) ratio for DELCATH SYSTEMS INC (DCTH) is 143.57 and the Price/Book (PB) ratio is 3.14.
Can you provide the financial health for DCTH stock?
The financial health rating of DELCATH SYSTEMS INC (DCTH) is 8 / 10.